Molecular mechanisms of action of BPA

Dose-Response

Volumn 13, Issue 4, 2015, Pages

  Acconcia, Filippo ^a   Pallottini, Valentina ^a   Marino, Maria ^a,b  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Bisphenol A; Endocrine disruptors; Low doses; Nuclear receptors; Signal transduction pathways

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANDROGEN RECEPTOR; ANDROSTENEDIONE; AROMATIC HYDROCARBON RECEPTOR; CALCIUM ION; CELL NUCLEUS RECEPTOR; CHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CONSTITUTIVE ANDROSTANE RECEPTOR; DNA; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RELATED RECEPTOR; ESTROGEN RELATED RECEPTOR GAMMA; G PROTEIN COUPLED RECEPTOR 30; HISTONE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREGNANE X RECEPTOR; PROTEIN KINASE B; RETINOID X RECEPTOR; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE; THYROID HORMONE RECEPTOR; THYROXINE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BINDING AFFINITY; BODY MASS; CALCIUM CELL LEVEL; CANCER GROWTH; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CHOLESTEROL TRANSPORT; DNA METHYLATION; ENDOCRINE DISEASE; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; EPIGENETICS; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENITAL SYSTEM; GOVERNMENT REGULATION; HEALTH HAZARD; HISTONE ACETYLATION; HORMONE METABOLISM; HUMAN; IC50; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; LIGAND BINDING; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PPAR GAMMA GENE; PREVALENCE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SAFETY; SIGNAL TRANSDUCTION; STEROID METABOLISM; STEROIDOGENESIS; STRUCTURE ANALYSIS; TOXICITY TESTING;

EID: 84946020432     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.1177/1559325815610582     Document Type: Article

References (96)

1. Dodds LW, Lawson W. Synthetic estrogenic agents without the phenanthrene nucleus. Nature. 1936;137:996
2. Geens T, Goeyens L, Covaci A. Are potential sources for human exposure to bisphenol-A overlooked? Int J Hyg Environ Health. 2011;214(5):339-347
3. Goodson A, Robin H, Summerfield W, Cooper I. Migration of bisphenol A from can coating – effects of damage, storage conditions and heating. Food Addit Contam. 2004;21(10):1015-1026
4. Bolli A, Galluzzo P, Ascenzi P, et al. Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor a-dependent rapid signals. IUBMB Life 2008;60(12): 843-852
5. Calafat AM, Weuve J, Ye X, et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect. 2009;117(4):639-644
6. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect. 2008;116(1):39-44
7. Braun JM, Kalkbrenner AE, Calafat AM, et al. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect. 2011;119(1):131-137
8. Van Landuyt KL, Nawrot T, Geebelen B, et al. How much do resin-based dental materials release? A meta-analytical approach. Dent Mater. 2011:27(8):723-747
9. Vivacqua A, Recchia AG, Fasanella G, et al. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine. 2003; 22(3):275-284
10. Geens T, Aerts D, Berthot C, et al. A review of dietary and nondietary exposure to bisphenol-A. Food Chem Toxicol. 2012; 50(10):3725-3740
11. Bushnik T, Haines D, Levallois P, Levesque J, Van Oostdam J, Viau C. Lead and bisphenol A concentrations in the Canadian population. Health Rep. 2010;21(3):7-18
12. Lakind JS, Levesque J, Dumas P, et al. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: bisphenol A intake as a case study. J Exposure Sci Environ Epidemiol. 2012;22(3):219-226
13. Koch HM, Kolossa-Gehring M, Schröter-Kermani C, Angerer J, Brüning T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol. 2012;22(6):610-616
14. U.S. Food and Drug Administration. Update on Bisphenol A (BPA) for Use in Food. Silver Spring, MD: US Food and Drug Administration; 2010
15. EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids). Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: Executive summary. EFSA Journal. 2015; 13(1):3978, 22. Web site. http://www.efsa.europa.eu/en/efsajournal/pub/3978.htm. Accessed 22 June 2015
16. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemical: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342
17. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9): 4097-40110
18. Bergman A, Heindel JJ, Kasten T, et al. The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect. 2013;121(4):a104-a106
19. Vandenberg LN, Colborn T, Hayes TB, et al. Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol. 2013;38: 1-15
20. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev. 2009;30(1): 75-95
21. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013;42:132-155
22. Carwile JL, Michels KB. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res. 2011;111(6):825-830
23. Wang T, Li M, Chen B, et al. Urinary bisphenol A (BPA)concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97(2):e223-e227
24. Oppeneer SJ, Robien K. Bisphenol A exposure and associations with obesity among adults: a critical review. Public Health Nutr. 2014;14(10):1-17
25. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES2003/06. PLoS One. 2010; 5(1):e8673
26. vom Saal FS, Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect. 2005;113(8):926-933
27. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 1997;105(1):70-76
28. Welshons WV, Nagel SC, Thayer KA, Judy BM, Vom Saal FS Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice. Toxicol Ind Health. 1999;15(1-2): 12-25
29. vom Saal FS, Timms BG, Montano MM, et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci USA. 1997;94(5):2056-2061
30. Sheng ZG, Tang Y, Liu YX, et al. Low concentrations of bisphenol a suppress thyroid hormone receptor transcription through a nongenomic mechanism. Toxicol Appl Pharmacol. 2012;259(1): 133-142
31. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378-455
32. Vandenberg LN. Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose-Response. 2013;12(2):259-276
33. De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health. 2012;2012:713696
34. Yoon K, Kwack SJ, Kim HS, Lee BM. Estrogenic endocrinedisrupting chemicals: molecular mechanisms of actions on putative human diseases. J Toxicol Environ Health B Crit Rev. 2014; 17(3):127-174
35. Bolli A, Bulzomi P, Galluzzo P, Acconcia F, Marino M. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth. IUBMB Life. 2010;62(9):684-687
36. Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor a and b: impact on human health. Mol Aspects Med. 2006;27(4):299-402
37. Marino M, Pellegrini M, La Rosa P, Acconcia F. Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes. Steroids. 2012;77(10):910-917
38. Pike AC, Brzozowski AM, Hubbard RE, et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 1999;18(17): 4608-4618
39. Eiler S, Gangloff M, Duclaud S, Moras D, Ruff M. Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Expr Purif. 2001;22(2):165-173
40. Hong EJ, Park SH, Choi KC, Leung PC, Jeung EB. Identification of estrogen-regulated genes by microarray analysis of the uterus of immature rats exposed to endocrine disrupting chemicals. Reprod Biol Endocrinol. 2006;4:49
41. McLachlan JA, Korach KS, Newbold RR, Degen GH. Diethylstilbestrol and other estrogens in the environment. Fundam Appl Toxicol. 1984;4(5):686-691
42. Acconcia F, Ascenzi P, Bocedi A, et al. Palmitoylationdependent estrogen receptor a membrane localization: regulation by 17b-estradiol. Mol Biol Cell. 2005;16(1):231-237
43. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERb palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr-Related Cancer. 2007;14(1):153-167
44. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem. 2007;282(31): 22278-22288
45. Marino M, Ascenzi P. Membrane association of estrogen receptor a and b influences 17b-estradiol-mediated cancer cell proliferation. Steroids. 2008;73(9-10):853-858
46. Acconcia F, Marino M. The effects of 17b-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane. Front Physiol. 2011;2:30
47. Wozniak AL, Bulayeva NN, Watson CS. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-a-mediated Ca2+ fluxes and prolactin release in GH3/ B6 pituitary tumor cells. Environ Health Perspect. 2005:113(4): 431-439
48. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ERalpha and ER beta. Mol Interv. 2003;3(5):281-292
49. La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F. Palmitoylation regulates 17b-estradiol-induced estrogen receptor-a degradation and transcriptional activity. Mol Endocrinol. 2012; 26(5):762-774
50. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Ann Rev Physiol. 2008;70: 165-190
51. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endo. 2010;204(2): 105-114
52. Otto C, Fuchs I, Kauselmann G, et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod. 2009;80(1):34-41
53. Levin ER. G protein-coupled receptor 30: estrogen receptor or collaborator? Endocrinology. 2009;150(4):1563-1565
54. Alonso-Magdalena P, Laribi O, Ropero AB, et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect. 2005;113(8): 969-977
55. Thomas P, Dong J. Binding and activation of the seventransmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol. 2006;102(1-5):175-179
56. Kortenkamp A, Martin O, Evans R, et al. Response to A critique of the European Commission Document, ‘‘State of the Art Assessment of Endocrine Disrupters’’ by Rhomberg and colleagues-letter to the editor. Crit Rev Toxicol 2012;42(9):787-789. author reply:790-791
57. Sohoni P, Sumpter JP. Several environmental oestrogens are also anti-androgens. J Endocrinol. 1998;158(3):327-339
58. Bulzomi P, Marino M. Environmental endocrine disruptors: does a sex-related susceptibility exist? Front Biosci (Landmark Ed). 2011;16:2478-2498
59. Wilson VS, Cardon MC, Gray LE Jr, Hartig PC. Competitive binding comparison of endocrine-disrupting compounds to recombinant androgen receptor from fathead minnow, rainbow trout, and human. Environ Toxicol Chem. 2007;26(9): 1793-1802
60. Pellegrini M, Acconcia F, Marino M. Endocrine disruptors: a gender affair. OA Biology 2013;1(1):5
61. Pellegrini M, Bulzomi P, Lecis M, et al. Endocrine disruptors differently influence estrogen receptor b and androgen receptor in male and female rat VSMC. J Cell Physiol. 2014;229(8): 1061-1068
62. Wetherill YB, Fisher NL, Staubach A, et al. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Res. 2005;65(1):54-65
63. Luccio-Camelo DC, Prins GS. Disruption of androgen receptor signaling in males by environmental chemicals. J Steroid Biochem Mol Biol. 2011;127(1-2):74-82
64. Weihua Z, Makela S, Andersson LC, et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A. 2001;98(11):6330-6335
65. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor g (ERRg) with high constitutive activity. Toxicol Lett. 2006;167(2):95-105
66. Zoeller RT. New insights into thyroid hormone action in the developing brain: the importance of T3 degradation. Endocrinology. 2010;151(11):5089-5091
67. Lin HY, Tang HY, Davis FB, et al. Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps. Discov Med. 2012;14(76):199-206
68. Iwamuro S, Yamada M, Kato M, Kikuyama S. Effects of bisphenol A on thyroid hormone-dependent up-regulation of thyroid hormone receptor alpha and beta and down-regulation of retinoid X receptor gamma in Xenopus tail culture. Life Sci. 2006;79(23): 2165-2171
69. di Masi A, De Marinis E, Ascenzi P, Marino M. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med. 2009;30(5):297-343
70. Sui Y, Ai N, Park SH, et al. Bisphenol A and its analogues activate human pregnane X receptor. Environ Health Perspect. 2012; 120(3):399-405
71. Rubin B, Soto AM. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol. 2009;304(1-2):55-62
72. Somm E, Schwitzgebel VM, Toulotte A, et al. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ Health Perspect. 2009;117(10):1549-1555
73. Swedenborg E, Ruegg J, Makela S, Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol. 2009;43(1):1-10
74. Riu A, Grimaldi M, le Maire A, et al. Peroxisome proliferatoractivated receptor g is a target for halogenated analogs of bisphenol A. Environ Health Perspect. 2011;119(9):1227-1232
75. Grün F. Obesogens. Curr Opin Endocrinol Diabetes Obes. 2010; 17(5):453-459
76. Cariou R, Antignac JP, Zalko D, et al. Exposure assessment of French women and their newborns to tetrabromobisphenol-A: occurrence measurements in maternal adipose tissue, serum, breast milk and cord serum. Chemosphere. 2008;73(7): 1036-1041
77. Abel J, Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem. 2010; 391(11):1235-1248
78. Nishizawa H, Imanishi S, Manabe N. Effects of exposure in utero to bisphenol a on the expression of aryl hydrocarbon receptor, related factors, and xenobiotic metabolizing enzymes in murine embryos. J Reprod Dev. 2005;51(5):593-605
79. Ziv-Gal A, Craig ZR, Wang W, Flaws JA. Bisphenol A inhibits cultured mouse ovarian follicle growth partially via the aryl hydrocarbon receptor signaling pathway. Reprod Toxicol. 2013; 42:58-67
80. Ohtake F, Takeyama K, Matsumoto T, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 2003;423(6939):545-550
81. Peretz J, Flaws JA. Bisphenol A down-regulates rate-limiting Cyp11a1 to acutely inhibit steroidogenesis in cultured mouse antral follicles. Toxicol Appl Pharmacol. 2013;271(2):249-256
82. Tabb MM, Blumberg B. New modes of action for endocrinedisrupting chemicals. Mol Endocrinol. 2006;20(3):475-482
83. Chong S, Whitelaw E. Epigenetic germline inheritance. Curr Opin Genet Dev. 2004;14(6):692-696
84. Ueda K. Effect of environmental chemicals on the genes and the gene expression. Yakugaku Zasshi. 2009;129(12):1501-1506
85. Mileva G, Baker SL, Konkle AT, Bielajew C. Bisphenol-A: epigenetic reprogramming and effects on reproduction and behavior. Int J Environ Res Public Health. 2014;11(7): 7537-7561
86. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006;66(11): 5624-5632
87. Gore AC. Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front Neuroendocrinol. 2008;29(3): 358-374
88. Anderson OS, Nahar MS, Faulk C, et al. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen. 2012;53(5): 334-342
89. Chiam K, Tilley WD, Butler LM, Bianco-Miotto T. The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers. Biochim Biophys Acta. 2009;1795(2):104-109
90. vom Saal FS, Akingbemi BT, Belcher SM, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24(2): 131-138
91. Wetheril YB, Petre CE, Monk KR, Puga A, Knudsen KE. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol Cancer Therap. 2002;1(7):515-524
92. Miyawaki J, Sakayama K, Kato H, Yamamoto H, Masuno H. Perinatal and postnatal exposure to bisphenol A increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb. 2007;14(5):245-252
93. Zsarnovszky A, Le HH, Wang HS, Belcher SM. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent non-genomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology. 2005;146(12):5388-5396
94. Correia AD, Freitas S, Scholze M, et al. Mixtures of estrogenic chemicals enhance vitellogenic response in sea bass. Environ Health Perspect. 2007;115 suppl:115-121
95. Zhang H, Kong FX, Yu Y, Shi XL, Zhang M, Tian HE. Assessing the combination effects of environmental estrogens in fish. Ecotoxicol. 2010;19(8):1476-1486
96. Watson CS, Jeng YJ, Guptarak J. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol. 2011;127(1-2):44-50.